Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients

NCT06448143 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Ureter Injury

Interventions

DRUG: Indigotindisulfonate sodium 0.8% injection

Sponsor

Prove pharm